Metamark Genetics metamarkgenetics.com


Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Metamark is a provider of specialty urological pathology testing services with the first fully integrated clinical model for the prostate cancer care pathway.

Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Metamark is a provider of specialty urological pathology testing services ...Show all

Company (Alive / Active)

All investors data 2 Investors

Phone: 617-583-1400

Fax:

283 Bear Hill Road

 Waltham, 02451
 Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Metamark Genetics $37.9M Nov 5, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Metamark Genetics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

Name Firm
Login to see detailsPhysiome Sciences
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tumor markers fus, smad4, derl1, ybx1, ps6, pdss2, cul2, and hspa9 for analyzing prostate tumor samples Jun 05, 2019 Application
Compositions and methods for cancer prognosis Mar 14, 2014 Application